Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05800600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Study acronym: Iron-RANC
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 1, 2026 to Feb 1, 2027
    • Study completion date: Feb 1, 2027 to Feb 1, 2028
    v5
  2. Primary completion date: Feb 1, 2025 to Feb 1, 2026
    • Study completion date: Feb 1, 2026 to Feb 1, 2027
    v4
  3. 2 versions Re-verified since Aug 23, 2023, no change to tracked fieldsv2-v3
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open-label, single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection.
Trial Details
NCT Number NCT05800600
Lead Sponsor Fox Chase Cancer Center
Conditions
(from sponsor)		 Anemia
Related terms Anemia
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov